Interferon-gamma-1a - Asubio Pharma

Drug Profile

Interferon-gamma-1a - Asubio Pharma

Alternative Names: Biogamma; SUN 4800

Latest Information Update: 11 Apr 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Asubio Pharma
  • Class Antineoplastics; Antivirals; Interferons; Lymphokines
  • Mechanism of Action Interferon stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Mycosis fungoides

Most Recent Events

  • 16 Sep 2005 Daiichi Suntory Pharma has been acquired by Daiichi Pharmaceutical
  • 06 Jan 2003 Suntory's pharmaceutical division has been transferred to a new joint venture of Suntory and Daiichi Pharmaceutical, Daiichi Suntory Pharma
  • 17 Jul 1992 Launched for Mycosis fungoides in Japan (Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top